1985
DOI: 10.1042/bj2280653
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of human tissue carnosinase

Abstract: Human tissue carnosinase (EC 3.4.13.3) had optimum activity at pH9.5 and was a cysteine peptidase, being activated by dithiothreitol and inhibited by p-hydroxymercuribenzoate. By optimizing assay conditions, the activity per g of tissue was increased 10-fold compared with values in the literature. The enzyme was present in every human tissue assayed and was entirely different from serum carnosinase. Highly purified tissue carnosinase had a broader specificity than hog kidney carnosinase. Although tissue carnos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
56
0
4

Year Published

1991
1991
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 108 publications
(62 citation statements)
references
References 21 publications
(22 reference statements)
2
56
0
4
Order By: Relevance
“…l-Carnosine is known to be hydrolyzed by a carnosinedegrading enzyme, carnosinase, which is present in several tissues and serum of humans or animals (Lenney et al, 1985;Kunze et al, 1986;Jackson et al, 1991;Nagai et al, 2003). These findings raise a possibility that enzymatic hydrolysis of exogenous l-carnosine by carnosinase may be involved in l-carnosine actions on ischemic ARF.…”
mentioning
confidence: 76%
See 1 more Smart Citation
“…l-Carnosine is known to be hydrolyzed by a carnosinedegrading enzyme, carnosinase, which is present in several tissues and serum of humans or animals (Lenney et al, 1985;Kunze et al, 1986;Jackson et al, 1991;Nagai et al, 2003). These findings raise a possibility that enzymatic hydrolysis of exogenous l-carnosine by carnosinase may be involved in l-carnosine actions on ischemic ARF.…”
mentioning
confidence: 76%
“…However, a possibility that l-carnosine improves the I/R-induced renal injury, at least in part, via its antioxidative activity cannot be ruled out, because oxidative stress is definitely involved in the pathogenesis of ischemic ARF (Chatterjee et al, 2000;Takaoka et al, 2002). l-Carnosine is decomposed to ␤-alanine and l-histidine by a carnosine-degrading enzyme, carnosinase, which is present in serum and several tissues (Lenney et al, 1985;Kunze et al, 1986;Jackson et al, 1991;Nagai et al, 2003). In rat brain, two types of carnosine-degrading enzymes are present: one enzyme is carnosinase, which preferentially hydrolyzes carnosine, and the other enzyme hydrolyzes ␤-alanyl-l-arginine considerably faster than carnosine, both of which do not degrade acetyl-l-carnosine (Kunze et al, 1986).…”
Section: Discussionmentioning
confidence: 99%
“…Both Lactococcus lactis and L. helveticus express biochemically identical dipeptidases, PepDA (459 amino acids) and cytosol nonspecific dipeptidase EC 3.4.13.18 (474 amino acids), which are approximately 30% identical and 47% similar to RAP (11). These enzymes are biochemically distinct from RAP, are specific for dipeptides of variable composition, and have been isolated from the cytoplasm of prokaryotic cells (34,35).…”
Section: Discussionmentioning
confidence: 99%
“…Although serum carnosinase activity has been well characterized (Lenney et al 1985;Pegova et al 2000;Dunnett et al 2002;Teufel et al 2003) using carnosine as a substrate, homocarnosine metabolism and the differential effects of the two primary substrates on CN1 activity have not been studied in detail. Furthermore, little is known concerning the relationship between carnosine and homocarnosine concentrations and CN1 activity in CSF.…”
Section: Introductionmentioning
confidence: 99%